Carlo Giovanni
Directeur/Membre du Conseil chez Bilayer Therapeutics, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Thomas A. Collet | M | - |
Bilayer Therapeutics, Inc.
 Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | 4 ans |
| Joshua Korzenik | M | - |
Bilayer Therapeutics, Inc.
Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | - |
| Robert Langer | M | 74 |
Bilayer Therapeutics, Inc.
Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | - |
| David Zhu | M | - |
Bilayer Therapeutics, Inc.
Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | - |
| Yen Chen Huang | M | - |
Bilayer Therapeutics, Inc.
Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 5 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Carlo Giovanni
- Réseau Personnel
